Hsin-Lun Lee

Assistant Professor, Department of Radiology
Visiting Staff, Taipei Medical University Hospital

https://orcid.org/0000-0002-2905-7858

Email132018@h.tmu.edu.tw

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Education

2014-2020 Ph.D., The Ph.D. Program for Translational Medicine, Taipei Medical University
2000-2007 M.D., School of Medicine, College of Medicine, Taipei Medical University

Experience

Attending Physician, Taipei Medical University Hospital
2021.01- Director, Division of Radiation Oncology, Taipei Medical University Hospital
2020.11- Assistant Professor, Department of Radiology, School of Medicine, College of Medicine, Taipei Medical University
2019.08-2020.12 Acting Director, Division of Radiation Oncology, Taipei Medical University Hospital
2014.04-2015.06 Adjunct Attending Physician, Taipei Medical University Hospital
2013.04-2014.09 Adjunct Attending Physician, Landseed International Hospital
2012.11-2015.06 Attending Physician, Taipei Municipal Wanfang Hospital

Fingerprint

Dive into the research topics where Hsin-Lun Lee is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

12 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots or

2 Finished

Stem Cell-Based Approaches and Organotypic Culture System for Dissecting Pathogenic Mechanisms and Establishing Therapeutic Strategies for Inflammatory Bowel Diseases and Gastrointestinal Cancer(3/3)
Lee, H.
8/1/19 → 7/31/20
Project: A - Government Institution › b - Ministry of Science and Technology
Investigating the Dynamic Change of Genotype and Phenotype in Circulating Tumor Cells and Its Clinical Significance in Cancer Progression
Lee, H.
8/1/19 → 7/31/20
Project: A - Government Institution › b - Ministry of Science and Technology

27 Citations
3 h-Index
12 Article

Pretreatment Neutrophil-to-Lymphocyte Ratio Predicts Survival and Liver Toxicity in Patients With Hepatocellular Carcinoma Treated With Stereotactic Ablative Radiation Therapy
Lo, C. H., Lee, H. L., Hsiang, C. W., Chiou, J. F., Lee, M. S., Chen, S. W., Shen, P. C., Lin, C. S., Chang, W. C., Yang, J. F., Dai, Y. H., Chen, C. Y., Chia-Hsien Cheng, J. & Huang, W. Y., Feb 1 2021, In: International Journal of Radiation Oncology Biology Physics. 109, 2, p. 474-484 11 p.
Research output: Contribution to journal › Article › peer-review
A combined systemic strategy for overcoming cisplatin resistance in head and neck cancer: From target identification to drug discovery
Chen, Y. J., You, G. R., Lai, M. Y., Lu, L. S., Chen, C. Y., Ting, L. L., Lee, H. L., Kanno, Y., Chiou, J. F. & Cheng, A. J., Nov 2020, In: Cancers. 12, 11, p. 1-20 20 p., 3482.
Research output: Contribution to journal › Article › peer-review

Open Access
Ex vivo expansion and drug sensitivity profiling of circulating tumor cells from patients with small cell lung cancer
Lee, H. L., Chiou, J. F., Wang, P. Y., Lu, L. S., Shen, C. N., Hsu, H. L., Burnouf, T., Ting, L. L., Chou, P. C., Chung, C. L., Lee, K. L., Shiah, H. S., Liu, Y. L. & Chen, Y. J., Nov 2020, In: Cancers. 12, 11, p. 1-17 17 p., 3394.
Research output: Contribution to journal › Article › peer-review

Open Access
Molecular-clinical correlation in pediatric medulloblastoma: A cohort series study of 52 cases in Taiwan
Wu, K. S., Ho, D. M. T., Jou, S. T., Yu, A. L., Tran, H. M., Liang, M. L., Chen, H. H., Lee, Y. Y., Chen, Y. W., Lin, S. C., Chang, F. C., Tsai, M. L., Liu, Y. L., Lee, H. L., Hsieh, K. L. C., Huang, W. C., Sung, S. Y., Chang, C. C., Changou, C. A., Liang, K. H. & 7 others, Hsieh, T. H., Liu, Y. R., Chao, M. E., Chen, W., Chu, S. S., Cho, E. C. & Wong, T. T., Mar 2020, In: Cancers. 12, 3, 653.
Research output: Contribution to journal › Article › peer-review

Open Access
1 Citation (Scopus)
Upregulation of protein synthesis and proteasome degradation confers sensitivity to proteasome inhibitor bortezomib in myc-atypical teratoid/rhabdoid tumors
Tran, H. M., Wu, K. S., Sung, S. Y., Changou, C. A., Hsieh, T. H., Liu, Y. R., Liu, Y. L., Tsai, M. L., Lee, H. L., Hsieh, K. L. C., Huang, W. C., Liang, M. L., Chen, H. H., Lee, Y. Y., Lin, S. C., Ho, D. M. T., Chang, F. C., Chao, M. E., Chen, W., Chu, S. S. & 4 others, Yu, A. L., Yen, Y., Chang, C. C. & Wong, T. T., Mar 22 2020, In: Cancers. 12, 3, 752.
Research output: Contribution to journal › Article › peer-review

Open Access

Active fraction (HS7) from Taiwanofungus camphoratus inhibits AKT-mTOR, ERK and STAT3 pathways and induces CDK inhibitors in CL1-0 human lung cancer cells
Lai, I. (Contributor), Lai, G. (Contributor), Chow, J. (Contributor), Lee, H. (Contributor), Yeh, C. (Contributor), Li, C. (Contributor), Yan, J. (Contributor), Chuang, S. (Contributor), Whang-Peng, J. (Contributor), Bai, K. (Contributor) & Yao, C. (Contributor), Unknown Publisher, Nov 15 2017
DOI: 10.6084/m9.figshare.c.3931717.v1, https://figshare.com/collections/Active_fraction_HS7_from_Taiwanofungus_camphoratus_inhibits_AKT-mTOR_ERK_and_STAT3_pathways_and_induces_CDK_inhibitors_in_CL1-0_human_lung_cancer_cells/3931717/1
Dataset
MOESM1 of Active fraction (HS7) from Taiwanofungus camphoratus inhibits AKT-mTOR, ERK and STAT3 pathways and induces CDK inhibitors in CL1-0 human lung cancer cells
Lai, I. (Contributor), Lai, G. (Contributor), Chow, J. (Contributor), Lee, H. (Contributor), Yeh, C. (Contributor), Li, C. (Contributor), Yan, J. (Contributor), Chuang, S. (Contributor), Whang-Peng, J. (Contributor), Bai, K. (Contributor) & Yao, C. (Contributor), Unknown Publisher, Nov 15 2017
DOI: 10.6084/m9.figshare.c.3931717_d1.v1, https://springernature.figshare.com/articles/journal_contribution/MOESM1_of_Active_fraction_HS7_from_Taiwanofungus_camphoratus_inhibits_AKT-mTOR_ERK_and_STAT3_pathways_and_induces_CDK_inhibitors_in_CL1-0_human_lung_cancer_cells/5606626/1
Dataset
MOESM2 of Active fraction (HS7) from Taiwanofungus camphoratus inhibits AKT-mTOR, ERK and STAT3 pathways and induces CDK inhibitors in CL1-0 human lung cancer cells
Lai, I. (Contributor), Lai, G. (Contributor), Chow, J. (Contributor), Lee, H. (Contributor), Yeh, C. (Contributor), Li, C. (Contributor), Yan, J. (Contributor), Chuang, S. (Contributor), Whang-Peng, J. (Contributor), Bai, K. (Contributor) & Yao, C. (Contributor), Unknown Publisher, Nov 15 2017
DOI: 10.6084/m9.figshare.c.3931717_d2.v1, https://springernature.figshare.com/articles/journal_contribution/MOESM2_of_Active_fraction_HS7_from_Taiwanofungus_camphoratus_inhibits_AKT-mTOR_ERK_and_STAT3_pathways_and_induces_CDK_inhibitors_in_CL1-0_human_lung_cancer_cells/5606662/1
Dataset
MOESM3 of Active fraction (HS7) from Taiwanofungus camphoratus inhibits AKT-mTOR, ERK and STAT3 pathways and induces CDK inhibitors in CL1-0 human lung cancer cells
Lai, I. (Contributor), Lai, G. (Contributor), Chow, J. (Contributor), Lee, H. (Contributor), Yeh, C. (Contributor), Li, C. (Contributor), Yan, J. (Contributor), Chuang, S. (Contributor), Whang-Peng, J. (Contributor), Bai, K. (Contributor) & Yao, C. (Contributor), Unknown Publisher, Nov 15 2017
DOI: 10.6084/m9.figshare.c.3931717_d3.v1, https://springernature.figshare.com/articles/journal_contribution/MOESM3_of_Active_fraction_HS7_from_Taiwanofungus_camphoratus_inhibits_AKT-mTOR_ERK_and_STAT3_pathways_and_induces_CDK_inhibitors_in_CL1-0_human_lung_cancer_cells/5606698/1
Dataset